Accrued Expense	3 Months Ended
Mar. 31, 2012
Accrued Expense	5. Accrued Expense As of March 31, 2012, Current Liabilities included accrued expense of $70,910. This includes approximate amounts for accrued expenses of $11,000 for consultant scientific advisory services, $7,600 for clinical trial operations, stock transfer fees of $2,900 and management bonus accrual totaling $48,000. As of March 31, 2012, Current Liabilities also included accrued expense related party consisting of $52,700 for clinical trial R&D hospital expenses related to MD Anderson treating patients in the Phase I clinical trial (see Note 2.).

5. Accrued Expense

As of March 31, 2012, Current Liabilities included accrued expense of $70,910. This includes approximate amounts for accrued expenses of $11,000 for consultant scientific advisory services, $7,600 for clinical trial operations, stock transfer fees of $2,900 and management bonus accrual totaling $48,000. As of March 31, 2012, Current Liabilities also included accrued expense related party consisting of $52,700 for clinical trial R&D hospital expenses related to MD Anderson treating patients in the Phase I clinical trial (see Note 2.).